StreetInsider.com News Articles

Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Raised to KRW590 at Nomura/Instinet

Tue, 02 Jun 2026 07:07:38 -0400

Nomura/Instinet analyst Shigeki Okazaki raised the price target on Sumitomo Chemical Co Ltd. (4005:JP) (OTC: SOMMY) to KRW590.00 (from KRW460.00) while maintaining a Neutral rating.

Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Raised to KRW590 at Nomura/Instinet

Tue, 02 Jun 2026 07:07:38 -0400

Nomura/Instinet analyst Shigeki Okazaki raised the price target on Sumitomo Chemical Co Ltd. (4005:JP) (OTC: SOMMY) to KRW590.00 (from KRW460.00) while maintaining a Neutral rating.

Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Raised to KRW590 at Nomura/Instinet

Tue, 02 Jun 2026 07:07:38 -0400

Nomura/Instinet analyst Shigeki Okazaki raised the price target on Sumitomo Chemical Co Ltd. (4005:JP) (OTC: SOMMY) to KRW590.00 (from KRW460.00) while maintaining a Neutral rating.

Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Raised to KRW590 at Nomura/Instinet

Tue, 02 Jun 2026 07:07:38 -0400

Nomura/Instinet analyst Shigeki Okazaki raised the price target on Sumitomo Chemical Co Ltd. (4005:JP) (OTC: SOMMY) to KRW590.00 (from KRW460.00) while maintaining a Neutral rating.

Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Lowered to KRW460 at Axis Capital Limited

Thu, 29 Jan 2026 03:57:09 -0400

Axis Capital Limited analyst Ankur Periwal lowered the price target on Sumitomo Chemical Co Ltd. (4005:JP) (OTC: SOMMY) to KRW460.00 (from KRW550.00) while maintaining a Add (2) rating.

Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Lowered to KRW460 at Axis Capital Limited

Thu, 29 Jan 2026 03:57:09 -0400

Axis Capital Limited analyst Ankur Periwal lowered the price target on Sumitomo Chemical Co Ltd. (4005:JP) (OTC: SOMMY) to KRW460.00 (from KRW550.00) while maintaining a Add (2) rating.

Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Lowered to KRW460 at Axis Capital Limited

Thu, 29 Jan 2026 03:57:09 -0400

Axis Capital Limited analyst Ankur Periwal lowered the price target on Sumitomo Chemical Co Ltd. (4005:JP) (OTC: SOMMY) to KRW460.00 (from KRW550.00) while maintaining a Add (2) rating.

Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Lowered to KRW460 at Axis Capital Limited

Thu, 29 Jan 2026 03:57:09 -0400

Axis Capital Limited analyst Ankur Periwal lowered the price target on Sumitomo Chemical Co Ltd. (4005:JP) (OTC: SOMMY) to KRW460.00 (from KRW550.00) while maintaining a Add (2) rating.

Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Raised to KRW460 at Nomura/Instinet

Mon, 19 Jan 2026 03:28:53 -0400

Nomura/Instinet analyst Shigeki Okazaki raised the price target on Sumitomo Chemical Co Ltd. (4005:JP) (OTC: SOMMY) to KRW460.00 (from KRW415.00) while maintaining a Neutral rating.

Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Raised to KRW460 at Nomura/Instinet

Mon, 19 Jan 2026 03:28:53 -0400

Nomura/Instinet analyst Shigeki Okazaki raised the price target on Sumitomo Chemical Co Ltd. (4005:JP) (OTC: SOMMY) to KRW460.00 (from KRW415.00) while maintaining a Neutral rating.

Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Raised to KRW460 at Nomura/Instinet

Mon, 19 Jan 2026 03:28:53 -0400

Nomura/Instinet analyst Shigeki Okazaki raised the price target on Sumitomo Chemical Co Ltd. (4005:JP) (OTC: SOMMY) to KRW460.00 (from KRW415.00) while maintaining a Neutral rating.

Sumitomo Chemical Co Ltd. (4005:JP) (SOMMY) PT Raised to KRW460 at Nomura/Instinet

Mon, 19 Jan 2026 03:28:53 -0400

Nomura/Instinet analyst Shigeki Okazaki raised the price target on Sumitomo Chemical Co Ltd. (4005:JP) (OTC: SOMMY) to KRW460.00 (from KRW415.00) while maintaining a Neutral rating.

Valent BioSciences partners with Seipasa for U.S. biostimulant market

Tue, 18 Nov 2025 10:00:29 -0400

Valent BioSciences LLC announced a strategic partnership with Seipasa to commercialize biostimulant products in the U.S. agricultural market. Under the agreement, Valent BioSciences will serve as the exclusive partner for Seipasa's biostimulant offerings in the United States.

The partnership centers on Seipasa's Sweetsei biostimulant product, which the Spanish company describes as designed to improve quality parameters in specialty crops through an optimized biochemical matrix that influences plant pathways. Seipasa currently markets Sweetsei in Latin America, Europe, and Africa.

"We are excited to enter this strategic partnership with a globally recognized research and development company," said Salman Mir, President and CEO of Valent

Valent BioSciences partners with Seipasa for U.S. biostimulant market

Tue, 18 Nov 2025 10:00:29 -0400

"We are excited to enter this strategic partnership with a globally recognized research and development company," said Salman Mir, President and CEO of Valent

Valent BioSciences partners with Seipasa for U.S. biostimulant market

Tue, 18 Nov 2025 10:00:29 -0400

"We are excited to enter this strategic partnership with a globally recognized research and development company," said Salman Mir, President and CEO of Valent

Valent BioSciences partners with Seipasa for U.S. biostimulant market

Tue, 18 Nov 2025 10:00:29 -0400

"We are excited to enter this strategic partnership with a globally recognized research and development company," said Salman Mir, President and CEO of Valent

Valent BioSciences partners with Seipasa for U.S. biostimulant market

Tue, 18 Nov 2025 10:00:29 -0400

"We are excited to enter this strategic partnership with a globally recognized research and development company," said Salman Mir, President and CEO of Valent

Valent BioSciences and Seipasa Form Strategic Partnership to Bring Novel Biostimulant Products to the U.S. Market

Tue, 18 Nov 2025 10:00:00 -0400

LIBERTYVILLE, Ill.--(BUSINESS WIRE)-- Valent BioSciences LLC and Seipasa announced today the formation of a strategic partnership to advance biostimulant technology offerings to the U.S. agricultural market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251118774681/en/